Cargando…
Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
Fabry disease (FD) is an X-linked hereditary defect of glycosphingolipid storage caused by mutations in the gene encoding the lysosomal hydrolase α-galactosidase A (GLA, α-gal A). To date, over 400 mutations causing amino acid substitutions have been described. Most of these mutations are related to...
Autores principales: | Lukas, Jan, Giese, Anne-Katrin, Markoff, Arseni, Grittner, Ulrike, Kolodny, Ed, Mascher, Hermann, Lackner, Karl J., Meyer, Wolfgang, Wree, Phillip, Saviouk, Viatcheslav, Rolfs, Arndt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731228/ https://www.ncbi.nlm.nih.gov/pubmed/23935525 http://dx.doi.org/10.1371/journal.pgen.1003632 |
Ejemplares similares
-
Fabry Disease – Underestimated in the Differential Diagnosis of Multiple Sclerosis?
por: Böttcher, Tobias, et al.
Publicado: (2013) -
Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene
por: Lukas, Jan, et al.
Publicado: (2012) -
Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients
por: Rolfs, Arndt, et al.
Publicado: (2013) -
Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice
por: Schlegel, Victoria, et al.
Publicado: (2016) -
A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease
por: Giese, Anne-Katrin, et al.
Publicado: (2015)